Guest Commentary
Artificial intelligence (AI) continues to upend how businesses operate, and the life sciences field is no exception. Generative AI provides life sciences companies the ability to identify and learn from patterns in large data sets. This use of AI has clear applications for the development of life-changing therapies. AI can assist companies with enhancing marketing strategies, driving developments in research and development, and making the manufacturing process more efficient—just to name a few examples.
The increased adoption of AI technologies also invites unique regulatory compliance risks stemming from the growing automation of certain business functions. At the same time, AI also offers companies the ability to innovate and improve their compliance functions.
AI compliance risks
The government is aware of the potential compliance risks accompanying the use of AI. The U.S. Department of Justice (DOJ) has a longstanding policy to consider the effectiveness of a company’s compliance program…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
